Zynex (ZYXI) Competitors $2.18 +0.03 (+1.40%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.22 +0.04 (+1.65%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. ZIMV, SNWV, NNOX, SMTI, NVRO, RCEL, NYXH, INGN, ELMD, and DRTSShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include ZimVie (ZIMV), SANUWAVE Health (SNWV), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Nevro (NVRO), AVITA Medical (RCEL), Nyxoah (NYXH), Inogen (INGN), Electromed (ELMD), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Zynex vs. ZimVie SANUWAVE Health Nano-X Imaging Sanara MedTech Nevro AVITA Medical Nyxoah Inogen Electromed Alpha Tau Medical ZimVie (NASDAQ:ZIMV) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation. Does the MarketBeat Community prefer ZIMV or ZYXI? Zynex received 24 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 55.56% of users gave Zynex an outperform vote while only 28.57% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformZimVieOutperform Votes628.57% Underperform Votes1571.43% ZynexOutperform Votes3055.56% Underperform Votes2444.44% Does the media refer more to ZIMV or ZYXI? In the previous week, Zynex had 24 more articles in the media than ZimVie. MarketBeat recorded 33 mentions for Zynex and 9 mentions for ZimVie. ZimVie's average media sentiment score of 1.02 beat Zynex's score of 0.04 indicating that ZimVie is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ZimVie 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zynex 1 Very Positive mention(s) 8 Positive mention(s) 20 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility and risk, ZIMV or ZYXI? ZimVie has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, Zynex has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Do analysts rate ZIMV or ZYXI? ZimVie presently has a consensus price target of $19.50, indicating a potential upside of 107.67%. Zynex has a consensus price target of $10.25, indicating a potential upside of 370.18%. Given Zynex's higher probable upside, analysts clearly believe Zynex is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZimVie 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is ZIMV or ZYXI more profitable? Zynex has a net margin of 2.49% compared to ZimVie's net margin of -77.31%. Zynex's return on equity of 13.05% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets ZimVie-77.31% 2.90% 1.17% Zynex 2.49%13.05%3.78% Do institutionals and insiders believe in ZIMV or ZYXI? 95.6% of ZimVie shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 3.0% of ZimVie shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has preferable earnings & valuation, ZIMV or ZYXI? Zynex has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimVie$449.75M0.58-$393.28M-$0.95-9.88Zynex$192.35M0.34$9.73M$0.0924.22 SummaryZynex beats ZimVie on 12 of the 19 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$65.90M$3.11B$5.31B$7.35BDividend YieldN/A1.82%5.47%4.31%P/E Ratio14.5314.8721.9417.82Price / Sales0.3443.57380.9497.68Price / Cash18.0144.0938.3134.64Price / Book1.603.336.453.98Net Income$9.73M$94.03M$3.22B$247.81M7 Day PerformanceN/A0.10%5.85%3.19%1 Month Performance-15.18%-9.43%-9.58%-7.70%1 Year Performance-80.84%-20.15%11.85%1.49% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex3.0295 of 5 stars$2.18+1.4%$10.25+370.2%-80.8%$65.90M$192.35M14.53770Analyst ForecastGap DownZIMVZimVie2.599 of 5 stars$9.34-1.4%$23.00+146.3%-39.1%$260.09M$449.75M-0.712,700SNWVSANUWAVE HealthN/A$30.18-1.6%N/AN/A$258.01M$32.63M-7.7440High Trading VolumeNNOXNano-X Imaging1.7611 of 5 stars$4.41+0.2%$12.00+172.1%-39.5%$254.81M$11.28M-5.19190Analyst ForecastNews CoverageGap UpSMTISanara MedTech1.7358 of 5 stars$27.55-0.9%$48.50+76.0%-12.9%$245.25M$86.67M-27.8360High Trading VolumeNVRONevro0.7172 of 5 stars$5.85+0.1%$6.43+9.9%-51.6%$224.32M$408.52M-3.091,215Analyst ForecastRCELAVITA Medical1.0837 of 5 stars$7.76+3.5%$17.25+122.3%+6.6%$203.45M$64.25M-3.25130NYXHNyxoah2.0863 of 5 stars$5.71-6.1%$14.75+158.3%-43.9%$194.48M$4.52M-3.05110Short Interest ↑Gap UpINGNInogen3.1756 of 5 stars$7.09+0.7%$7.00-1.3%+1.0%$190.63M$335.71M-3.151,030Short Interest ↓Positive NewsGap UpHigh Trading VolumeELMDElectromed1.0454 of 5 stars$22.16-1.0%$38.00+71.5%+57.2%$189.62M$59.63M29.55160Positive NewsDRTSAlpha Tau Medical2.7161 of 5 stars$2.45-2.8%$8.00+226.5%-1.9%$172.43MN/A-5.7080Short Interest ↓News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies ZimVie Alternatives SANUWAVE Health Alternatives Nano-X Imaging Alternatives Sanara MedTech Alternatives Nevro Alternatives AVITA Medical Alternatives Nyxoah Alternatives Inogen Alternatives Electromed Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZYXI Stock Free ZYXI Stock Alerts